<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02493907</url>
  </required_header>
  <id_info>
    <org_study_id>[2014] ethics register [34]</org_study_id>
    <nct_id>NCT02493907</nct_id>
  </id_info>
  <brief_title>Corrected Left Ventricular Electrical Delay Predicting Response to Cardiac Resynchronization Therapy</brief_title>
  <official_title>A Prospective Clinical Trial of Corrected Left Ventricular Electrical Delay Predicting Response to Cardiac Resynchronization Therapy in Chinese With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Southern Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital with Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac resynchronization therapy (CRT) is a well-established treatment for patients with&#xD;
      severe systolic heart failure (HF) and ventricular desynchronization. Despite the&#xD;
      consistently observed structural and functional improvements as well as reductions in HF&#xD;
      events and mortality in large multicenter randomized trials, 30% patients remain classified&#xD;
      as nonresponders. Present evidences showed that QRS duration was the most effective parameter&#xD;
      to predict responsivity of CRT in patients with severe HF. But some studies showed that QRS&#xD;
      duration could be influenced by obesity and gender. Accordingly, the simple QRS interval&#xD;
      width of body surface electrocardiograph should not be the most satisfactory parameter for&#xD;
      screening patients suitable for CRT. Recent study showed that left ventricular electrical&#xD;
      delay, as measured by the time from the onset of QRS to the LV electrogram peak (QLV),&#xD;
      predicted CRT response. At long QLV intervals, atrioventricular optimization (AVO) can&#xD;
      increase the likelihood of structural response to CRT. However, it is unclear whether it is&#xD;
      suitable for Chinese patients. The investigators would like to validate this relation in a&#xD;
      Chinese population and explore if a corrected QLV might do better to predict the responsivity&#xD;
      of CRT.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular End Systolic Volume (LVESV)</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>change in LVESV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA)</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>change in NYHA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular ejection fraction (LVEF)</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>change in LVEF</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Cardiac Resynchronization Therapy</condition>
  <arm_group>
    <arm_group_label>heart failure</arm_group_label>
    <description>heart failure patients with CRT</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients received CRT in Sun Yat-sen Memorial Hospital, Sun Yat-sen&#xD;
        University. Informed consent must be obtained for all of the included patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  •More than 18 Years&#xD;
&#xD;
               -  Informed consent signed&#xD;
&#xD;
               -  NYHA class ≥ II, an ejection fraction of ≤ 0.35, QRS duration of ≥ 150&#xD;
                  milliseconds with Non-LBBB) or ≥ 120 milliseconds with LBBB, who treated with CRT&#xD;
&#xD;
               -  The Estimated survival time was more than one year&#xD;
&#xD;
               -  sinus rhythm, pacemaker independent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  •NYHA class I symptoms&#xD;
&#xD;
               -  Severe liver or kidney dysfunction&#xD;
&#xD;
               -  Valvular heart disease&#xD;
&#xD;
               -  Pregnancy or lactation women&#xD;
&#xD;
               -  percutaneous coronary intervention (PCI) or cardiac artery bypass graft (CABG)&#xD;
                  within 3 month&#xD;
&#xD;
               -  Have malignant tumors and the Estimated survival time was less than one year&#xD;
&#xD;
               -  an enzyme-positive myocardial infarction within 3 months before enrollment, or&#xD;
                  atrial fibrillation&#xD;
&#xD;
               -  any reasons cannot complete follow-up; Or researchers think that don't suit to be&#xD;
                  included in the research of other conditions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jingfeng Wang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Lei, M.D., Ph.D.</last_name>
    <phone>+86-13650894373</phone>
    <email>leijuan_1@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Lei, M.D., Ph.D.</last_name>
      <phone>+86-13650894373</phone>
      <email>leijuan_1@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>July 2, 2015</study_first_submitted>
  <study_first_submitted_qc>July 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2015</study_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Jingfeng Wang</investigator_full_name>
    <investigator_title>subdecanal</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

